Successful treatment of leptomeningeally metastasised pituitary carcinoma with temozolomide

Publication date

2017-12

Authors

van Der Vlist, A.
Snijders, T. J.ORCID 0000-0003-0857-081XISNI 000000039373112X
Stades, A. M.E.ISNI 0000000391475775
Spliet, W. G.M.ISNI 0000000395008605
De Vos, F. Y.F.L.ORCID 0000-0002-9082-5991ISNI 0000000395290102

Editors

Advisors

Supervisors

DOI

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

A 69-year-old man presented with leptomeningeally metastasised pituitary carcinoma, rapidly progressing despite previous treatment with resection, radiotherapy and cabergoline. The patient received temozolomide chemotherapy, resulting in a complete clinical, radiological and biochemical response after 14 cycles, which has been maintained since then. This case lends further support to the role of temozolomide in refractory pituitary tumours.

Keywords

Pituitary carcinoma, Prolactinoma, Temozolomide, Taverne, Internal Medicine

Citation

van Der Vlist, A, Snijders, T J, Stades, A M E, Spliet, W G M & De Vos, F Y F L 2017, 'Successful treatment of leptomeningeally metastasised pituitary carcinoma with temozolomide', Netherlands Journal of Medicine, vol. 75, no. 10, pp. 451-454.